DrugPatentWatch Database Preview
Elusys Therapeutics Inc Company Profile
» See Plans and Pricing
US Patents for Elusys Therapeutics Inc
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Elusys Therapeutics Inc | ANTHIM | obiltoxaximab | INJECTABLE;INJECTION | 125509 | 001 | 2016-10-20 | 10,590,182 | The Regents of the University of California (Oakland, CA) | 2035-02-24 | RX | Orphan | search |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
